The healthcare of tomorrow: assessing the innovation landscape in Europe

In her role of Senior Vice-President, Head of European Markets, Monica Shaw leads BMS’s business across Europe, with a portfolio of innovative medicines spanning oncology, hematology, cardiovascular, immunology, cell therapy and neurology. Shaw joined BMS from Oncopeptides, a global biotechnology company, where she served as Chief Executive Officer. She has held several international leadership positions at Leo Pharma, GSK/ViiV Healthcare, Merck Serono and Novartis, with experience across immunology, dermatology, oncology, virology, neurology and rare diseases. Previously, Shaw also worked as a doctor at the UK’s National Health Service.

Tamsin Rose is a facilitator who was until recently a senior fellow for health at Friends of Europe. Having studied international relations, she has 25 years of experience working across the European continent from Ireland to Mongolia. A natural communicator, Tamsin has been a radio reporter, worked on press for the EU Delegation in Moscow and is currently a member of the external speaker team for the European Commission Directorate-General for Communication, describing how the EU works and key policies to visitor groups from around the world. Since 2002, she has specialised in public health and public participation issues, serving as the Secretary General of the European Public Health Alliance (EPHA), and providing strategic advice for health groups on how to engage successfully with the EU.